|
- Introduced brain-imaging analysis products, including Neurophet AQUA AD, which enables monitoring of adverse effects related to Alzheimer's disease treatments
- Highlighted clinical value of Neurophet AQUA AD…To accelerate efforts across healthcare institutions in Southeast Asia
SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced on 9th that it participated in a symposium held on the 28th of last month (local time). The event was hosted by the Southeast Asian Consortium on Neurocognition, Neuroimaging and Biomarker Research (SEACURE) at Nanyang Technological University (NTU), Singapore.
At the symposium, Neurophet operated an exhibition booth and showcased its major AI-powered brain imaging analysis solutions, including Neurophet AQUA AD, a software that supports monitoring of Alzheimer's disease treatment prescription, therapeutic effect, and adverse effects.
During the event, Hyunkook Lim, Chief Medical Officer (CMO) of Neurophet and Director of the Catholic Brain Health Center at Yeouido St. Mary's Hospital, along with Nagaendran Kandiah, a leading dementia expert and professor at the Lee Kong Chian School of Medicine, NTU, presented detailed use cases and clinical research outcomes involving Neurophet's AI-based brain imaging analysis solutions.
Hyunkook Lim, CMO of Neurophet, delivered a presentation titled "Neurophet a Game-Changer in Clinical Practice: Real-World Cases of Dementia Treatment Efficacy & Side Effect Management." He highlighted real-world cases from clinical settings in Korea using Neurophet AQUA AD and emphasized its clinical value in enhancing the safety of Alzheimer's disease treatment administration.
Professor Nagaendran Kandiah presented on the topic "Automatic Brain Segmentation in Cognitive Impairment: Validation of AI-based AQUA Software in the Southeast Asian BIOCIS Cohort." His detailed research finding demonstrated the clinical validity of Neurophet AQUA, a neurodegeneration imaging analysis software, in patients with mild cognitive impairment and dementia.
Jake Junkil Been, Co-CEO of Neurophet, stated, "By presenting the clinical value of Neurophet AQUA AD at this symposium, we further strengthened the evidence supporting its clinical utility," adding, "We plan to accelerate the expansion of Neurophet AQUA AD across healthcare institutions in the Southeast Asian region."
Meanwhile, the symposium concluded successfully with the participation of approximately 220 neurologists across six Southeast Asian countries, including Singapore, Indonesia, Malaysia, the Philippines, Thailand, and Vietnam.
About Neurophet
Neurophet specializes in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain disorders based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Co-CEOs Jake Junkil Been and Donghyeon Kim, who developed the next-generation neuro-navigation system.
Major products include brain MRI analysis software "Neurophet AQUA", PET Image Quantitative Analysis Software "Neurophet SCALE PET", Brain imaging treatment planning software for electric and magnetic brain stimulation "Neurophet tES/TMS LAB", Alzheimer's Disease treatment prescription and monitoring software "Neurophet AQUA AD" for tracking treatment efficacy and side effects, and Multiple Sclerosis image analysis software "Neurophet AQUA MS".
Neurophet has set its top priority to helping patients suffering from brain disorders. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain's health and pioneer solutions for brain diseases with AI technology.
- Introduced brain-imaging analysis products, including Neurophet AQUA AD, which enables monitoring of adverse effects related to Alzheimer's disease treatments
- Highlighted clinical value of Neurophet AQUA AD…To accelerate efforts across healthcare institutions in Southeast Asia
SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced on 9th that it participated in a symposium held on the 28th of last month (local time). The event was hosted by the Southeast Asian Consortium on Neurocognition, Neuroimaging and Biomarker Research (SEACURE) at Nanyang Technological University (NTU), Singapore.
At the symposium, Neurophet operated an exhibition booth and showcased its major AI-powered brain imaging analysis solutions, including Neurophet AQUA AD, a software that supports monitoring of Alzheimer's disease treatment prescription, therapeutic effect, and adverse effects.
During the event, Hyunkook Lim, Chief Medical Officer (CMO) of Neurophet and Director of the Catholic Brain Health Center at Yeouido St. Mary's Hospital, along with Nagaendran Kandiah, a leading dementia expert and professor at the Lee Kong Chian School of Medicine, NTU, presented detailed use cases and clinical research outcomes involving Neurophet's AI-based brain imaging analysis solutions.
Hyunkook Lim, CMO of Neurophet, delivered a presentation titled "Neurophet a Game-Changer in Clinical Practice: Real-World Cases of Dementia Treatment Efficacy & Side Effect Management." He highlighted real-world cases from clinical settings in Korea using Neurophet AQUA AD and emphasized its clinical value in enhancing the safety of Alzheimer's disease treatment administration.
Professor Nagaendran Kandiah presented on the topic "Automatic Brain Segmentation in Cognitive Impairment: Validation of AI-based AQUA Software in the Southeast Asian BIOCIS Cohort." His detailed research finding demonstrated the clinical validity of Neurophet AQUA, a neurodegeneration imaging analysis software, in patients with mild cognitive impairment and dementia.
Jake Junkil Been, Co-CEO of Neurophet, stated, "By presenting the clinical value of Neurophet AQUA AD at this symposium, we further strengthened the evidence supporting its clinical utility," adding, "We plan to accelerate the expansion of Neurophet AQUA AD across healthcare institutions in the Southeast Asian region."
Meanwhile, the symposium concluded successfully with the participation of approximately 220 neurologists across six Southeast Asian countries, including Singapore, Indonesia, Malaysia, the Philippines, Thailand, and Vietnam.
About Neurophet
Neurophet specializes in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain disorders based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Co-CEOs Jake Junkil Been and Donghyeon Kim, who developed the next-generation neuro-navigation system.
Major products include brain MRI analysis software "Neurophet AQUA", PET Image Quantitative Analysis Software "Neurophet SCALE PET", Brain imaging treatment planning software for electric and magnetic brain stimulation "Neurophet tES/TMS LAB", Alzheimer's Disease treatment prescription and monitoring software "Neurophet AQUA AD" for tracking treatment efficacy and side effects, and Multiple Sclerosis image analysis software "Neurophet AQUA MS".
Neurophet has set its top priority to helping patients suffering from brain disorders. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain's health and pioneer solutions for brain diseases with AI technology.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Neurophet Introduced Use Cases of Its AI-based Brain Imaging Analysis Solutions at the SEACURE Symposium Hosted by Nanyang Technological University in Singapore
BANGKOK, Dec. 11, 2025 /PRNewswire/ -- Central Chidlom, under Central Retail, in collaboration with United International Pictures, successfully wrapped an exclusive experience by transforming the G Floor of Central Chidlom into a magical fantasy world with WICKED: FOR GOOD EXPERIENCE — the first and only immersive installation of its kind in Thailand. This extraordinary showcase brought to life key scenes from the highly anticipated film WICKED: FOR GOOD through a fully immersive and lifelike environment. Visitors were invited to step into the enchanting world of Elphaba and Glinda to experience the magic and emotion of this global cinematic phenomenon before the epic conclusion of WICKED: FOR GOOD on the big screen, premiering in cinemas nationwide.
Central Chidlom Transforms into a Realm of Enchantment
Step into a world of wonder as Central Chidlom was transformed into a magical realm, beginning from the BTS Skywalk at Chitlom Station. The journey was unfolded through the Sky Terrace, adorned with fantastical trees, leading into the first floor of Central Chidlom and down to the G floor — reimagined as seven immersive chambers of magic. Each room captured the beauty and power of friendship, brought to life through a realistic, cinematic atmosphere inspired by the world of WICKED. Visitors could feel as though they've stepped into the story itself, where the enchanting bond between Elphaba and Glinda reminds us that true friendship has the power to transform us for the better. Adding to the spectacle, the exterior façade of Central Chidlom glowed and shifted in colour each evening throughout the month, reflected the iconic themes of WICKED and invited all to experience the magic.
The successful collaboration underscores Central Chidlom's dedication to bringing international entertainment experiences to Thailand while driving cultural engagement and memorable customer moments. It also reflects the strong partnership between Central Retail and United International Pictures, working together to deliver unique, cinematic-level experiences to Thai consumers.
Enjoy seamless shopping throughout the experience via Central's convenient platforms: Central App, website: https://www.central.co.th, Central Chat & Shop, Facebook Live and Inbox: https://www.facebook.com/CentralDepartmentStore and Central TikTok Shop
#WickedForGoodExperience #CentralChidlom #TheStoreofBangkok
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Central Chidlom, The Store of Bangkok Unveils Thailand's First Immersive WICKED Experience
